Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$2.13 USD
-0.12 (-5.33%)
Updated May 24, 2024 04:00 PM ET
After-Market: $2.17 +0.04 (1.88%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $-0.18 | 4.67% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of $0.34 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 525.00%. Look out for ESPR's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 60.87%.
Earnings History
Price & Consensus
Zacks News for ESPR
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services